Murphy Matthew B.
SEC insider (Form 3/4/5 filer). CIK 0001865778. General Counsel at Nautilus Biotechnology, Inc. (NAUT). 3 reported Form 4/5 transactions since Sep 2024; latest on Mar 2, 2026. Located in SEATTLE, WA.
Companies Murphy Matthew B. has filed insider reports for
- Nautilus Biotechnology, Inc. (NAUT): Officer, General Counsel
Murphy Matthew B.
CIK: 0001865778
Transaction Breakdown
Open Market Buys (P)1 (33.3%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (66.7%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
NAUT
Nautilus Biotechnology, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Mar 2, 2026NAUT
Nautilus Biotechnology, Inc.
AwardDirectStock Option (Right to Buy)
160K shares- - Sep 4, 2025NAUT
Nautilus Biotechnology, Inc.
PurchaseIndirect20K shares at avg. $0.64$13K - Mar 3, 2025NAUT
Nautilus Biotechnology, Inc.
AwardDirectStock Option (Right to Buy)
160K shares-
1-3 of 3 transactions